Current directions in IBD therapy: what goals are feasible with biological modifiers?
Sandborn
William J
WJ
Inflammatory Bowel Disease Clinic, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA. william@mayo.edu
D001685:Biological Factors / Q000627:therapeutic use*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000276:immunology; D017410:Practice Guidelines as Topic; D012074:Remission Induction / Q000379:methods
D001685:Biological Factors